Class IITerminated in FDA datasetRecall initiated Oct 30, 2013

Dietary Supplements packaged in the following configurations: (1) 7263 Kirk Enz-Comp-W-TG UNL,…

Recalling firm: National Enzyme Co

Why it was recalled

Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Mar 3, 2015.

Check your package

Compare the exact product and package details with the label you have.

ProductDietary Supplements packaged in the following configurations: (1) 7263 Kirk Enz-Comp-W-TG UNL, packaged in unlabeled, 90-capsule bottles (SKU 52939); (2) 7263 Kirk Enz-Comp-W-TG UNL2, packaged in unlabeled 180-capsule bottles (SKU 53852);

FDA code information

Lot #'s: 52939039, 52939040, 52939042, 52939043, 53852011, 53852012, 53852013, 53852015, and 53852016

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Dietary Supplements packaged in the following configurations: (1) 7263 Kirk Enz-Comp-W-TG UNL, packaged in unlabeled, 90-capsule bottles (SKU 52939); (2) 7263 Kirk Enz-Comp-W-TG UNL2, packaged in unlabeled 180-capsule bottles (SKU 53852);

Original FDA recall reason

Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol

Recall details

Recall number
F-0755-2014
Event ID
66658
FDA status
Terminated
Initiated
Oct 30, 2013
Reported
Dec 25, 2013
Classified
Dec 13, 2013
Terminated
Mar 3, 2015
Quantity
16444 bottles
Location
Forsyth, MO, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Domestic distribution of the product is nationwide with direct accounts in 27 states in all geographical regions. Foreign distribution consists of direct accounts in the following countries: Canada, China, Malaysia, Norway, Slovakia, South Korea, Sweden, Taiwan, and the United Kingdom.

FDA source record · F-0755-2014

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.